BCL2 and colorectal carcinoma: Our in silico analysis has revealed the microRNA‐497 (miR‐497) as one of the most iterated miRNAs in CRC, as will be detailed later on, and the B‐cell lymphoma 2 (BCL2) gene as one of its target genes that proved previously to play a central role in the regulation of apoptosis and was implicated in colorectal carcinogenesis, progression, and treatment resistance.12